Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease

The American Journal of Cardiology
Khadija Lahlou-LaforetSilla M Consoli

Abstract

The increased risk of coronary heart disease (CHD) associated with depression is well documented. We hypothesized that impaired fibrinolysis is involved in this link. To explore the association of depressive mood and/or vital exhaustion with various measurements of fibrinolysis activity, 231 men (40 to 65 years old; 123 without CHD and taking no medication and 108 with documented CHD), completed the Center of Epidemiologic Studies Depression Scale and the Maastricht Questionnaire for vital exhaustion. Using classic cut-off points (Center of Epidemiologic Studies Depression Scale score >or=17, Maastricht Questionnaire score >or=8), 6.5% and 9.8% of subjects without CHD and 38% and 48.1% of those with CHD were classified as depressed and exhausted, respectively. Patients with CHD were older, had a higher body mass index, and higher levels of total cholesterol, glucose, plasminogen activator inhibitor 1 (PAI-1), tissue plasminogen activator (t-PA) antigen, and fibrinogen; 47% were treated for hypertension. Depressed subjects had higher levels of PAI-1 activity (p = 0.006) and exhausted patients had higher levels of PAI-1 activity (p = 0.011) and fibrinogen (p = 0.009). After adjusting for clinical condition (with or without CHD), ...Continue Reading

References

Oct 1, 1987·International Journal of Cardiology·A AppelsP Mulder
Mar 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·K RäikkönenA Hautanen
Jun 13, 1998·Psychosomatic Medicine·W J KopA Appels
Jan 27, 1999·Journal of the American Geriatrics Society·A N DentinoH J Cohen

❮ Previous
Next ❯

Citations

Jan 16, 2013·Journal of Cardiovascular Pharmacology·Xiao-Ting LuFan Jiang
Jul 7, 2010·Psychiatry and Clinical Neurosciences·Yanyan ShiGang Hou
Aug 6, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Antti-Pekka ElomaaSoili M Lehto
Jun 15, 2007·Journal of Thrombosis and Thrombolysis·Roland von KänelKristina Orth-Gomér
Dec 3, 2014·Physiology & Behavior·Mimi TangLihong Zhang
Mar 24, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Elsa IsingriniVincent Camus
Jun 23, 2009·Journal of Psychosomatic Research·Roland von KänelBrigitte M Kudielka
Nov 29, 2015·Aging Clinical and Experimental Research·Malgorzata Gorska-CiebiadaJerzy Loba
Nov 26, 2010·Psychiatry Research·Cornel Victor IgnaHannu Vanhanen
May 31, 2016·Acta Psychiatrica Scandinavica·H VulserC Lemogne
Nov 29, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Verena SchroederHans P Kohler
Jul 27, 2010·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Gilberto Paz-FilhoMa-Li Wong
Mar 24, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·René KrummenacherRoland von Känel
Jan 2, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Anna Paola CellaiDomenico Prisco
Jun 25, 2008·Stress : the International Journal on the Biology of Stress·Brigitte M KudielkaRoland von Känel
Aug 7, 2019·Journal of Neuroscience Research·Eric Zhang, Ping Liao
Nov 23, 2019·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Roland von KänelMarcus Ising
Jan 31, 2019·European Heart Journal·Viola VaccarinoUNKNOWN ESC Scientific Document Group Reviewers
Oct 16, 2019·Acta Neuropathologica Communications·Hélène PartyVéronique Agin
Feb 12, 2020·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Selena T Nguyen-RodriguezKrista M Perreira
Apr 21, 2021·The European Journal of Neuroscience·Ellen DoneyCaroline Menard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.